In this study, we propose a Dual-Path Parallel Fusion Network (MDPNet) for multimodal MRI-based glioma genotyping, specifically targeting three critical genetic biomarkers: IDH, 1p/19q, and ATRX. This evidence concerns the gene ATRX and central nervous system cancer.